SuperworthMereo BioPharma shares outstanding MREO
Diluted shares outstanding, averaged over each quarter, from 2023.
- Latest quarter, to Jun 30, 2026
- 803.6M
- On a year earlier
- +0.5%
- more shares
Mereo BioPharma had 803.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 0.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 800.4M | +3% |
| FY2024 | 774.8M | +11% |
| FY2023 | 699.4M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 803.6M | +1% | |
| Q1 FY26 | 801.8M | +2% | |
| Q4 FY25 | 800.4M | +3% | |
| Q3 FY25 | 799.9M | +4% | |
| Q2 FY25 | 799.4M | +12% | |
| Q1 FY25 | 784.3M | +12% | |
| Q4 FY24 | 774.8M | +11% | |
| Q3 FY24 | 770.1M | +12% | |
| Q2 FY24 | 711.8M | +13% | |
| Q1 FY24 | 700.3M | +12% | |
| Q4 FY23 | 699.4M | n/a | |
| Q3 FY23 | 685M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Mereo BioPharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.